Abstract
HI6(pyridinium, 1-[[[4-(aminocarbonyl)pyridinio] methoxy]methyl]-2-[(hydroxyimino)methyl]-dichloride belongs to a series of bisquaternary pyridinium oximes that are effective against poisoning with extremely toxic organophosphates. Since HI6 has been shown to be unstable at pH 7.4 and to release significant amounts of cyanide, a study was undertaken to determine the degree of cyanide formation from HI 6 in vivo. When HI 6 (100 μmol/kg) was administered i. v. to dogs, the animals showed no signs of cyanide toxicity but exhibited some cholinomimetic symptoms, including retching, hypersalivation and enhanced intestinal motility. Cyanide content in whole blood was monitored after production of methemoglobinemia (30%) by 4-dimethylaminophenol in order to sequester cyanide within red cells. Maximal cyanide contents of 20 μmol/l were found in blood after 90 min. Calculation of the area under the concentration versus time curve for blood cyanide indicates that about 4% of HI 6 produced cyanide. Determination of the pharmacokinetic parameters of HI 6 (VD=0.31 l/kg; kel=0.76 h−1) and of cyanide (VD=0.086 l/kg; kel=0.52 h−1) together with the apparent first order rate constant of cyanide formation from HI 6 in vitro (0.174 h−1, pH 7.4, 37°) allowed the simulation of a cyanide concentration curve that fitted with the experimental data points, indicating that cyanide formation in vivo was not bio-catalyzed. It is concluded that cyanide formation from HI 6 may not be regarded as a potential hazard, since cyanide elimination exceeded markedly its formation. Whether this conclusion also holds true for man has to be established.
Similar content being viewed by others
References
Askew BM, Davies DR, Green AL, Holmes R (1956) The nature of the toxicity of 2-oxo-oximes. Br J Pharmacol 11: 424–427
Beetlestone JG, Irvine DH (1964) Reactivity differences between haemoglobins. I. The ionization of human methaemoglobins. Proc R Soc A 277: 401–413
Boxer GE, Rickards JC (1952) Studies on the metabolism of the carbon of cyanide and thiocyanate. Arch Biochem Biophys 39: 7–25
Catsimpoolas N, Wood JL (1964) The reaction of cyanide with bovine serum albumin. J Biol Chem 239: 4132–4137
Christel D, Eyer P, Hegemann M, Kiese M, Lörcher W, Weger N (1977) Pharmacokinetics of cyanide in poisoning of dogs, and the effect of 4-dimethylaminophenol or thiosulfate. Arch Toxicol 38: 177–189
Christenson I (1968) Hydrolysis of bis(4-hydroxyiminomethyl-1-pyridiniomethyl) ether dichloride (Toxogonin) 1. Decomposition products. Acta Pharm Suec 5: 23–36
Christenson I (1972) Hydrolysis of obidoxime chloride (Toxogonin) III. Kinetics in neutral and alkaline solution. Acta Pharm Suec 9: 309–322
Creasey NH, Green AL (1959) 2-Hydroxyiminomethyl-N-methyl-pyridinium methane-sulphonate (P2S), an antidote to organophosphorus poisoning. Its preparation, estimation and stability. J Pharm Pharmacol 11: 485–490
Ellin RI (1958) Stability of pyridine-2-aldoxime methiodide I. Mechanism of breakdown in aqueous alkaline solution. J Am Chem Soc 80: 6588–6590
Ellin RI, Easterday DE, Zvirblis P, Kondritzer AA (1966) Kinetics of deterioration of trimethylene bis-(4-formylpyridinium bromide)dioxime in dilute aqueous solutions. J Pharm Sci 55: 1263–1267
Enander I, Sundwall A, Sörbo B (1961) Metabolic studies on N-methylpyridinium-2-aldoxime. I. The conversion to thiocyanate. Biochem Pharmacol 7: 226–231
Enander I, Sundwall A, Sörbo B (1962) Metabolic studies on N-methylpyridinium-2-aldoxime III. Experiments with the [14C]-labelled compound. Biochem Pharmacol 11: 377–382
Eyer P, Hell W (1985) Chemical stability of the Hagedorn oximes HGG 12 and HI 6 Arch Pharm 318: 938–946
Eyer P, Hell W (1986) Untersuchung des Zerfalls von HGG 12 in wäßriger Lösung. Arch Pharm 319: 558–566
Eyer P, Hertle H, Kiese M, Klein G (1975) Kinetics of ferrihemoglobin formation by some reducing agents, and the role of hydrogen peroxide. Mol Pharmacol 11: 326–334
Eyer P, Lierheimer E, Schneller M (1984) Reactions of nitrosochloramphenicol in blood. Biochem Pharmacol 33: 2299–2308
Eyer P, Hell W, Kawan A, Klehr H (1986) Studies on the decomposition of the oxime HI 6 in aqueous solution. Arch Toxicol 59: 266–271
Kiese M (1959) Oxidation von Anilin zu Nitrosobenzol im Hunde. Arch Exp Path Pharmacol 235: 354–359
Klimmek R, Eyer P (1986) Pharmacokinetics and pharmacodynamics of the oxime HI 6 in dogs. Arch Toxicol 59: 272–278
Klimmek R, Fladerer H, Weger N (1979a) Circulation, respiration, and blood homeostasis in cyanide-poisoned dogs after treatment with 4-dimethylaminophenol or cobalt compounds. Arch Toxicol 43: 121–133
Klimmek R, Fladerer H, Szinicz L, Weger N, Kiese M (1979b) Effects of 4-dimethylaminophenol and Co2EDTA on circulation, respiration, and blood homeostasis in dogs. Arch Toxicol 42: 75–84
Kušić R, Bošković B, Vojvodić J, Jovanović D (1985) HI 6 in man: Blood levels, urinary excretion, and tolerance after intramuscular administration of the oxime to healthy volunteers. Fund Appl Toxicol 5: S89-S97
Ligtenstein DA (1984) The synergism of HI 6 and atropine in organophosphate intoxications. Thesis Leiden/Netherlands
Marcov V, Rakin D, Binenfeld Z (1984) Hidroliza 1-(2-hidroksiiminometil-1-piridinijum)-3-(4-karbamoil-1-piridinijum)-2-oksapropan dihlorida (HI 6). Ispitivanje, stabilnosti vodenhi rastvora. Naucno-technicki pregled 34: 19–24
McMillan DE, Svoboda AC (1982) The role of erythrocytes in cyanide detoxification. J Pharmacol Exp Ther 221: 37–42
Michenfelder JD (1977) Cyanide release from sodium nitroprusside in the dog. Anesthesiology 46: 196–201
Nagashima S (1978) Spectrophotometric determination of cyanide with sodium isonicotinate and sodium barbiturate. Anal Chim Acta 99: 197–201
Nickerson M, Thomas JJ (1951) Renal excretion of thiocyanate. J Lab Clin Med 38: 194–198
Philipović I, Vukušić I (1983) Stability of oxime HI 6 in acidic solutions. Abstract of the Second International Meeting on Cholinesterases. Bled
Rowland M, Tucker GT (1986) Pharmacokinetics: theory and methodology. Pergamon, Oxford
Schoene K, Hochrainer D, Oldiges H, Krügel M, Franzes N, Brickert HJ (1985) The protective effect of oxime pretreatment upon inhalative toxicity of sarin and soman in rats. Fund Appl Toxicol 5: S84-S88
Scholer H (1964) Das Blutvolumen, Versuch einer Deutung seines Wesens. Med. Welt 4: 182–188
Schulz V (1984) Clinical pharmacokinetics of nitroprusside, cyanide, thiosulfate and thiocyanate. Clin Pharmacokinet 9: 239–251
Simons KJ, Briggs CJ (1983) The pharmacokinetics of HI 6 in beagle dogs. Biopharm Drug Dispos 4: 375–388
Smith RG, Mukerji B, Seaburg KH (1940) Thiocyanate formation in cyanide poisoning by methylene blue and sodium nitrite. J Pharmacol 68: 351–364
Sylvester DM, Hayton WL, Morgan RL, Way JL (1983) Effects of thiosulfate on cyanide pharmacokinetics in dogs. Toxicol Appl Pharmacol 69: 265–271
Vesey CJ, Wilson J (1978) Red cell cyanide. J Pharm Pharmacol 30: 20–26
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Eyer, P., Kawan, A. & Ladstetter, B. Formation of cyanide after i. v. administration of the oxime HI 6 to dogs. Arch Toxicol 61, 63–69 (1987). https://doi.org/10.1007/BF00324550
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00324550